Adage Capital Partners’s CONMED CNMD Stock Holding History

Adage Capital Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$11.2M	–	964
2020 Q4	$11.2M	Buy	100,000 +25,000	+33%	+$2.37M	0.02%	561
2020 Q3	$5.9M	Sell	75,000 -5,000	-6%	-$408K	0.01%	608
2020 Q2	$5.76M	Buy	+80,000	New	+$5.57M	0.01%	601
2020 Q1	–	Sell	-90,000	Closed	-$10.1M	–	743
2019 Q4	$10.1M	Sell	90,000 -55,000	-38%	-$5.86M	0.02%	535
2019 Q3	$13.9M	Hold	145,000	–	–	0.03%	450
2019 Q2	$12.4M	Buy	+145,000	New	+$11.9M	0.03%	489
2018 Q1	–	Sell	-50,000	Closed	-$2.55M	–	726
2017 Q4	$2.55M	Sell	50,000 -100,000	-67%	-$5.21M	0.01%	656
2017 Q3	$7.87M	Buy	150,000 +50,000	+50%	+$2.51M	0.02%	589
2017 Q2	$5.09M	Buy	+100,000	New	+$4.95M	0.01%	632

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Adage Capital Partners's CNMD Position: Q1 2021 in Review

Adage Capital Partners sold out of CONMED (CNMD) in Q1 2021, closing a stake of 100,000 shares — an estimated $11.2M sold.

Adage Capital Partners first reported a position in CNMD in Q2 2017 and held it in 9 quarters. The position peaked at $13.9M in Q3 2019. 238 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

Adage Capital Partners reported no remaining CONMED position as of Q1 2021 after selling out during the quarter.
Adage Capital Partners sold 100,000 CONMED shares in Q1 2021, an estimated $11.2M.
Adage Capital Partners first reported a position in CONMED in Q2 2017 and held it in 9 quarters.
Adage Capital Partners's CONMED position peaked at $13.9M in Q3 2019.
238 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.